L Groop, PH Groop, S Stenman, C Saloranta, … - Diabetes Care, 1987 - Am Diabetes Assoc Fourteen non-insulin-dependent diabetic (NIDDM) patients continued their
previous medication (7 on glyburide, 7 on glipizide) for 6 mo, after which they
switched to the alternate treatment for another 6 mo. The treatment periods ... Cited by 45 - Related articles - All 4 versions
- ►annals.org S Stenman, A Melander, PH Groop, LC Groop - Annals of internal medicine, 1993 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
What Is the Benefit of Increasing the Sulfonylurea Dose? Cited by 60 - Related articles - All 3 versions
T Rydberg, A Jönsson, M Røder, A Melander - Diabetes care, 1994 - Am Diabetes Assoc OBJECTIVE--To assess the hypoglycemic effect and the insulin-releasing effect of
the main glyburide (glibenclamide) metabolites 4-trans-hydroxy-glibenclamide
(M1) and 3-cis-hydroxy-glibenclamide (M2) in humans. RESEARCH DESIGN AND ... Cited by 43 - Related articles - BL Direct - All 5 versions
PO Bitzen, A Melander, B Schersten, E Wåhlin … - European journal of clinical pharmacology, 1988 - Springer Summary. An early defect in subjects with non-in- sulin-dependent diabetes
mellitus (NIDDM) and the preceding phase of impaired glucose tolerance (IGT) is
a reduction in early insulin release and hence a prolonged elevation of ... Cited by 9 - Related articles - All 4 versions
LC Groop, N Barzilai, K Ratheiser, L Luzi, E … - Diabetes Care, 1991 - Am Diabetes Assoc OBJECTIVE: To examine the relationship between plasma glyburide concentrations
(0, 50, 100, 200, 400, and 800 nM) and the insulin response and glucose
metabolism during euglycemic (4.6 +/- 0.1 mM) and hyperglycemic (11.6 +/- ... Cited by 41 - Related articles - All 5 versions
[CITATION] Sulfonylureas: basic aspects and clinical uses
HE Lebovitz, A Melander - International textbook of diabetes mellitus, 1997 - Wiley & Sons Ltd Cited by 42 - Related articles
A Jönsson, T Rydberg, G Ekberg, B … - Diabetes Care, 1994 - Am Diabetes Assoc OBJECTIVE--To determine the terminal elimination half-life of glyburide in
non-insulin-dependent diabetes mellitus (NIDDM) subjects after cessation of
long-term treatment. RESEARCH DESIGN AND METHODS--Ten NIDDM patients (5 of ... Cited by 28 - Related articles - BL Direct - All 5 versions
L Siconolfi-Baez, MA Banerji, HE Lebovitz - Diabetes care, 1990 - ncbi.nlm.nih.gov This study describes and characterizes a putative sulfonylurea receptor. The
radioligand used was [3H]glipizide (9 Ci/mmol). The beta-cell plasma membranes
were derived from a transplantable rat insulinoma generated by subcutaneous ... Cited by 31 - Related articles
